CD70 and neoplasm: In the organoid-PBMC co-culture system, both anti-CD70 monotherapy and anti-PD-1 monotherapy significantly increased tumor cell death, but combination therapy exhibited greater tumor-killing efficacy in terms of the organoid number, size, and viability (Figs. 4k–n).